The Association of Post-COVID-19–Related Symptoms and Preceding Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Fully Vaccinated Paramedics in Canada
- 31 October 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 229 (4) , 1019-1025
Abstract
This study investigated the association between previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and risk of symptoms associated with post-COVID conditions among fully vaccinated paramedics in Canada. We included vaccinated paramedics who provided blood sample and questionnaire data on the same date during the study period. We examined the presence of symptoms associated with post-COVID conditions and depression severity against prior SARS-CoV-2 infection categories. Compared to the “no previous SARS-CoV-2 infection” group, there was no detected association between known prior SARS-CoV-2 infection (odds ratio [OR], 1.42 [95% confidence interval {CI}, 0.96–2.09]), nor unknown prior SARS-CoV-2 infection (OR, 0.54 [95% CI, 0.29–1.00]), and the presence of symptoms associated with post-COVID conditions.Keywords
Funding Information
- Government of Canada
- COVID-19 Immunity Task Force
- Michael Smith Health Research British Columbia
- Centre for Health Evaluation and Outcome Sciences Research Trainee award
This publication has 12 references indexed in Scilit:
- Self-Reported Long COVID and Its Association with the Presence of SARS-CoV-2 Antibodies in a Danish Cohort up to 12 Months after InfectionMicrobiology Spectrum, 2022
- Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in GermanyPLOS Medicine, 2022
- Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 InfectionsOpen Forum Infectious Diseases, 2022
- Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care WorkersJAMA, 2022
- Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2The Lancet, 2022
- The Costs of Long COVIDJAMA Health Forum, 2022
- Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillanceClinical Microbiology and Infection, 2021
- Estimating total morbidity burden of COVID-19: relative importance of death and disabilityJournal of Clinical Epidemiology, 2021
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparisonThe Lancet Infectious Diseases, 2020
- Persistent Symptoms in Patients After Acute COVID-19JAMA, 2020